Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wallace, D. K.
Right arrow Articles by Steinkuller, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallace, D. K.
Right arrow Articles by Steinkuller, P. G.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ocular Medications in Children

David K. Wallace, MD

Departments of Ophthalmology and Pediatrics, The University of North Carolina at Chapel Hill, NC

Paul G. Steinkuller, MD

Cullen Eye Institute, Baylor College of Medicine, and Ophthalmology Service, Texas Children's Hospital, Houston, TX

Many ocular medications are used by pediatricians or ophthalmologists caring for pediatric patients. Topical antibiotics are commonly prescribed for bacterial conjunctivitis, nasolacrimal duct obstructions, and ophthalmia neonatorum. Many new antiallergy eye drops are now available for the treatment of seasonal (hay fever) conjunctivitis. Dilating eye drops and antiglaucoma medications are generally used or prescribed by ophthalmologists, but pediatricians must be aware of their potentially serious systemic side effects. Before initiating treatment, physicians should evaluate the risks and benefits of ophthalmic medications, establish minimum dosages necessary to achieve a therapeutic benefit, and monitor children for local and systemic side effects.

Clinical Pediatrics, Vol. 37, No. 11, 645-652 (1998)
DOI: 10.1177/000992289803701101
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NeoReviewsHome page
T. E. Young
Pharmacology Review: Topical Mydriatics: The Adverse Effects of Screening Examinations for Retinopathy of Prematurity
NeoReviews, June 1, 2003; 4(6): e163 - 166.
[Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
C. Roberts
Comparison of the Ocular Comfort of Ofloxacin 0.3% Ophthalmic Solution and Lubricant Eye Drops
Clinical Pediatrics, April 1, 2002; 41(3): 151 - 154.
[PDF]